Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO)-Reference-Cited by-同舟云学术

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO)

Published:2019-12 Issue:12 Volume:25 Page:2388-2397
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Candoni Anna,Rambaldi Alessandro,Fanin Renato,Velardi Andrea,Arcese William,Ciceri Fabio,Lazzarotto Davide,Lussana Federico,Olivieri Jacopo,Grillo Giovanni,Parma Matteo,Bruno Benedetto,Sora Federica,Bernasconi Paolo,Saccardi Riccardo,Foà Robin,Sessa Mariarosa,Bresciani Paola,Giglio Fabio,Picardi Alessandra,Busca Alessandro,Sica Simona,Perruccio Katia,Zucchetti Elisa,Diral Elisa,Iori Anna Paola,Colombo Anna Amelia,Tringali Stefano,Santarone Stella,Irrera Giuseppe,Mancini Stefano,Zallio Francesco,Malagola Michele,Albano Francesco^ORCID,Carella Angelo Michele,Olivieri Attilio,Tecchio Cristina,Dominietto Alida,Vacca Adriana,Sorasio Roberto,Orciuolo Enrico,Risitano Antonio Maria,Leotta Salvatore,Cortelezzi Agostino,Mammoliti Sonia,Oldani Elena,Bonifazi Francesca

Funder

European Society of Blood and Bone Marrow Transplantation,

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference46 articles.

1. Current treatment of Philadelphia chromosome positive acute lymphoblastic leukemia;Fielding;Hematology Am Soc Hematol Educ Program,2011

2. Management of Adult Ph-positive acute lymphoblastic leukemia;Chiaretti;Hematology Am Soc Hematol Educ Program,2015

3. Allogeneic hematopoietic stem cell transplant in Philadelphia-positive acute lymphoblastic leukaemia;Fielding;Bone Marrow Transplant,2008

4. Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome–positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993

5. Chemotherapy-phased imatinib pulses improve long-term outcome of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: Northern Italy Leukemia Group protocol 09/00;Bassan;J Clin Oncol,2010

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemotherapy-free treatment of VAF induces early and deep molecular response in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a prospective, single-center, single-arm, phase 2 trial;2024-07-12

2. SOHO State of the Art Updates and Next Questions, Measurable Residual Disease in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia;Clinical Lymphoma Myeloma and Leukemia;2024-07

3. Ponatinib as a Prophylactic or Pre-Emptive Strategy to Prevent Cytological Relapse after Allogeneic Stem Cell Transplantation in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Transplanted in Complete Cytological Remission;Cancers;2024-05-31

4. Impact of minimal residual disease response and of status of disease on survival after blinatumomab in B-cell acute lymphoblastic leukemia: results from a real-life study;Annals of Hematology;2024-04-13

5. Impact of minimal residual disease response and of status of disease on survival after Blinatumomab in B-Cell Acute Lymphoblastic Leukemia: results from a Real-Life Study. Running title: MRD-response and Disease Status correlate with survival after Blinatumomab in ALL-B patients;2024-03-05